US
Sanofi’s Meningococcal Conjugate Vaccine secures FDA approval in patients aged two and up
April 27, 2020Sales and Marketing FDA, MenQuadfi, Sanofi, US, meningococcal disease, pharma
Sanofi’s MedQuadfi Meningococcal Conjugate Vaccine has scored FDA approval for the prevention of invasive meningococcal disease, becoming the first and …
How the intended role of generic medicines is being undermined in America
April 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, US, feature, generic medicines, generics
The introduction of a generic medicine should, in theory, incentivise companies to lower the price of the original drug, creating healthy …
US approval for haemophilia drug derived from genetically engineered rabbit’s milk
April 2, 2020Sales and Marketing FDA, US, haemophilia, pharma
The FDA has announced the approval of Sevenfact, a haemophilia therapy the active ingredient from which is expressed in genetically …
The April 2020 issue of Pharmafocus is available to read free online now!
April 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, UK, US, coronavirus, generic medicines, pharma, rare disease, real world data, real-world data
The latest monthly edition of Pharmafocus, the April 2020 issue, is available to read for free online now! There’s one …
FDA invokes emergency powers to authorise 30-minute, handheld COVID-19 test
March 27, 2020Medical Communications, Sales and Marketing COVID-19, FDA, Mesa Biotech, US, coronavirus
The FDA invoked Emergency Use Authorization powers to approve a rapid, handheld testing kit for COVID-19 coronavirus cases just days …
US continues sanctions against Iran despite coronavirus ravaging both nations
March 23, 2020Manufacturing and Production, Sales and Marketing Iran, Iran US, US, coronavirus
The Trump administration is not relaxing sanctions on Iran, despite the country having one of the highest death tolls from …
European Commission offers €80m to CureVac to develop coronavirus vaccine
March 17, 2020Manufacturing and Production, Research and Development, Sales and Marketing CureVac, EU, US, coronavirus
Following confirmation of reports that US President Donald Trump sought to persuade a biotech to provide US-exclusivity for a potential …
FDA gives emergency authorisation to first coronavirus tests
March 17, 2020Manufacturing and Production, Sales and Marketing FDA, Roche, US, coronavirus
The coronavirus crisis in the US has thus far been characterised by a lack of testing within its population. This …
Trump tried to solicit US-exclusivity for coronavirus vaccine, report claims
March 16, 2020Sales and Marketing CureVac, Trump, US, coronavirus, pharma
President Trump has attracted criticism from all sides over his response to the novel coronavirus outbreak; after repeatedly downplaying the …
FDA halts overseas inspections over coronavirus concerns
March 11, 2020Research and Development, Sales and Marketing FDA, US, approvals, pharma
The FDA has responded to the ongoing COVID-19 coronavirus outbreak by announcing that it will halt all inspections of overseas …
Acacia Pharma secures first FDA approval with Barhemsys for postoperative nausea and vomiting
February 28, 2020Medical Communications, Sales and Marketing Acacia, FDA, UK, US, pharma
UK-based Acacia Pharma has secured its first US approval with the FDA’s decision to authorise Barhemsys (amisulpride injection) for the …
US Judge rules that a decade of unpublished trial results must be made public
February 27, 2020Medical Communications, Research and Development FDA, US, clinical trials, pharma
A federal judge in New York’s Southern District has ruled that 10 years of unpublished clinical trial data must now …
First US coronavirus trial launched into Gilead’s remdesivir
February 26, 2020Research and Development FDA, Gilead, US, coronavirus, pharma
The first US clinical trial investigating a treatment for the COVID-19 coronavirus has been launched by the US National Institute …
US domestic supply of 150 drugs under threat from coronavirus outbreak
February 25, 2020Manufacturing and Production MERS, Sars, US, US Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus
Disruption to the US drug production pipeline from the coronavirus could hurt its domestic supply of 150 drugs. US senators …
Read the January/February 2020 edition of Pharmafocus online now!
January 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma
Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …
Latest content
FibroFind appoints Lee Borthwick as CEO
